VHCP Management as of June 30, 2011
Portfolio Holdings for VHCP Management
VHCP Management holds 14 positions in its portfolio as reported in the June 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals (IRWD) | 19.7 | $38M | 2.4M | 15.72 | |
| Neurocrine Biosciences (NBIX) | 13.3 | $26M | 3.2M | 8.05 | |
| Chelsea Therapeutics International | 10.4 | $20M | 3.9M | 5.10 | |
| NPS Pharmaceuticals | 9.0 | $17M | 1.8M | 9.45 | |
| Ardea Biosciences | 6.8 | $13M | 509k | 25.46 | |
| Anacor Pharmaceuticals In | 6.8 | $13M | 2.0M | 6.46 | |
| DepoMed | 6.3 | $12M | 1.5M | 8.18 | |
| GTx | 5.1 | $9.8M | 2.0M | 4.79 | |
| Medivation | 4.9 | $9.4M | 437k | 21.43 | |
| Affymax (AFFY) | 4.8 | $9.3M | 1.4M | 6.87 | |
| DURECT Corporation | 4.7 | $9.0M | 4.4M | 2.03 | |
| Anthera Pharmaceuticals | 2.9 | $5.5M | 675k | 8.17 | |
| ACADIA Pharmaceuticals (ACAD) | 2.9 | $5.5M | 3.4M | 1.63 | |
| Antares Pharma | 2.4 | $4.6M | 2.1M | 2.21 |
